Literature DB >> 24253538

Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.

Frank Modersitzki1, Laura Pizzi, Michael Grasso, David S Goldfarb.   

Abstract

Cystinuria is a genetic cause of recurrent kidney stones which may be more recurrent and larger than more common non-cystine stones. They may have a greater impact on health-related quality of life (HRQoL). We measured this impact by surveying HRQoL in patients with stones, comparing non-cystine stone formers (NCSF) to cystine stone formers (CYSF) and both groups to normative values of the US population. We used SF-36v2 via an internet instrument. CYSF patients were recruited via cystinuria-related websites, two patient advocacy groups, and an active endourology practice. NCSF patients were recruited from the same practice and by email. Total n surveyed with scorable data: 214 CYSF and 81 NCSF. The participants included 128 men and 161 women. The group of CYSF were significantly younger (39 vs. 54 years) and suffered longer from kidney stones (255 vs. 136 months). CYSF patients had significantly more episodes of stones than NCSF patients in the last year (N = 108 CYSF, N = 20 NCSF). More frequent stones in the last year and mental comorbidities most often predicted worse scores in the individual HRQoL domains. However, cystine stone composition was a significant predictor of worse scores only for role emotional. Better scores in all SF-36 domains were associated with greater time since the last kidney stone event. Although kidney stones are often transient, kidney stone formers, regardless of stone composition, have a worse HRQoL than the standard US population, which has a normative score of 50, such as general health (41.2 ± 12.8), bodily pain (46.5 ± 11.8) and mental health (45.1 ± 12.6). CYSF are more frequent and severe stone formers compared with NCSF with a resulting greater, direct impact on the HRQoL of CYSF patients. Whether preventive strategies for cystinuria are being properly utilized by practitioners, and which strategies are most effective, should be established.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24253538      PMCID: PMC4514515          DOI: 10.1007/s00240-013-0621-4

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  14 in total

1.  Longitudinal evaluation of the SF-36 quality of life questionnaire in patients with kidney stones.

Authors:  Chester J Donnally; Amit Gupta; Karim Bensalah; Altug Tuncel; Jay Raman; Margaret S Pearle; Yair Lotan
Journal:  Urol Res       Date:  2010-10-06

2.  Impact of chronic conditions on quality of life in patients with inflammatory bowel disease.

Authors:  Laura T Pizzi; Christine M Weston; Neil I Goldfarb; Deborah Moretti; Nicole Cobb; Jamie B Howell; Anthony Infantolino; Anthony J Dimarino; Sidney Cohen
Journal:  Inflamm Bowel Dis       Date:  2006-01       Impact factor: 5.325

3.  Association of depression and urolithiasis.

Authors:  Jordan Angell; Michael Bryant; Hukang Tu; Michael Goodman; John Pattaras; Kenneth Ogan
Journal:  Urology       Date:  2011-12-03       Impact factor: 2.649

4.  Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date?

Authors:  David S Goldfarb
Journal:  Rev Urol       Date:  2002

5.  Development of an instrument to assess the health related quality of life of kidney stone formers.

Authors:  Kristina L Penniston; Stephen Y Nakada
Journal:  J Urol       Date:  2012-09-24       Impact factor: 7.450

6.  Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?

Authors:  Christopher S Saigal; Geoffrey Joyce; Anga R Timilsina
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

7.  Increased risk of depressive disorder within 1 year after diagnosis with urinary calculi in Taiwan.

Authors:  Shiu-Dong Chung; Joseph J Keller; Herng-Ching Lin
Journal:  Psychiatry Res       Date:  2012-03-13       Impact factor: 3.222

Review 8.  Cystinuria.

Authors:  Aditya Mattoo; David S Goldfarb
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

Review 9.  Economics and cost of care of stone disease.

Authors:  Yair Lotan
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

10.  Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification.

Authors:  Luca Dello Strologo; Elon Pras; Claudia Pontesilli; Ercole Beccia; Vittorino Ricci-Barbini; Luisa de Sanctis; Alberto Ponzone; Michele Gallucci; Luigi Bisceglia; Leopoldo Zelante; Maite Jimenez-Vidal; Mariona Font; Antonio Zorzano; Ferran Rousaud; Virginia Nunes; Paolo Gasparini; Manuel Palacín; Gianfranco Rizzoni
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

View more
  11 in total

Review 1.  Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Authors:  Amrik Sahota; Jay A Tischfield; David S Goldfarb; Michael D Ward; Longqin Hu
Journal:  Urolithiasis       Date:  2018-12-04       Impact factor: 3.436

Review 2.  The nutrition consult for recurrent stone formers.

Authors:  Kristina L Penniston
Journal:  Curr Urol Rep       Date:  2015-07       Impact factor: 3.092

3.  Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.

Authors:  Charles C Mikel; David S Goldfarb; Amy Ponte; Katherine Steigelman; Sergey Latyshev
Journal:  Urolithiasis       Date:  2022-10-06       Impact factor: 2.861

Review 4.  Kidney stones.

Authors:  Saeed R Khan; Margaret S Pearle; William G Robertson; Giovanni Gambaro; Benjamin K Canales; Steeve Doizi; Olivier Traxer; Hans-Göran Tiselius
Journal:  Nat Rev Dis Primers       Date:  2016-02-25       Impact factor: 52.329

5.  Case Study - Case Studies in Cystinuria.

Authors:  David S Goldfarb; Michael Grasso
Journal:  Urol Nurs       Date:  2017 Mar-Apr

Review 6.  A Complete World Literature Review of Quality of Life (QOL) in Patients with Kidney Stone Disease (KSD).

Authors:  Francesca New; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2016-12       Impact factor: 3.092

7.  Translation and Linguistic Validation of the Korean Version of the Wisconsin Stone Quality of Life Questionnaire.

Authors:  Young Eun Yoon; Sung Yong Cho
Journal:  Int Neurourol J       Date:  2020-03-31       Impact factor: 2.835

8.  Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases.

Authors:  Rosanne M Smits; Eline Vissers; Rosan Te Pas; Noor Roebbers; Wout F J Feitz; Iris A L M van Rooij; Ivo de Blaauw; Chris M Verhaak
Journal:  Orphanet J Rare Dis       Date:  2022-04-04       Impact factor: 4.123

9.  Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy.

Authors:  Frank Modersitzki; David S Goldfarb; Ross L Goldstein; Roger L Sur; Kristina L Penniston
Journal:  Urolithiasis       Date:  2019-12-13       Impact factor: 3.436

Review 10.  Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review.

Authors:  Carlota Pascoal; Sandra Brasil; Rita Francisco; Dorinda Marques-da-Silva; Agnes Rafalko; Jaak Jaeken; Paula A Videira; Luísa Barros; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2018-11-28       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.